Study: Inflammation Might Impact Reflux to Esophageal Cancer Progression
A new study reveals inflammation might play a role in the progression from reflux to esophageal cancer, according to a news release.
The study was published in Clinical Gastroenterology and Hepatology, the journal of the American Gastroenterological Association.
The study's researchers looked at almost 34,000 patients with reflux disease. They found more than 26,000 of the patients had erosive reflux disease and 37 subsequently developed esophageal cancer. The incidence of esophageal cancer among these patients with erosive reflux disease was significantly greater than what is expected for the general population, according to the new release.
"Our research shows that damage to the esophageal lining that can be seen with endoscopy is important in the progression from normal cells to cancer, and Barrett's esophagus is likely to be an intermediate step," said Rune Erichsen, MD, of Aarhus University Hospital in Denmark and lead author of this study, in the release.
Related Articles on Gastroesophageal Reflux Disease:
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- How Physician Thinking Changes After Working in ACOs
- 2014 Financial Impact Analysis Doesn't Stop With CMS' Final Rule: Don't Neglect CMS NCCI Edits
- 4 Drivers of Recent M&A Activity in Healthcare
- 8 Reasons to Outsource Medical Billing Services
- 5 ICD-10 Transition Considerations Medical Practices Have Likely Not Thought About